Seer (NASDAQ:SEER) Stock Price Up 1.2% – Still a Buy?

Seer, Inc. (NASDAQ:SEER)’s share price rose 1.2% on Friday . The stock traded as high as $1.7250 and last traded at $1.72. Approximately 96,250 shares traded hands during trading, a decline of 53% from the average daily volume of 203,020 shares. The stock had previously closed at $1.70.

Analyst Ratings Changes

SEER has been the topic of several research reports. Canaccord Genuity Group initiated coverage on shares of Seer in a research report on Monday, May 4th. They set a “buy” rating and a $4.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a report on Tuesday, April 21st. Finally, TD Cowen raised shares of Seer to a “strong-buy” rating in a report on Monday, April 13th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $4.00.

Seer Trading Up 1.2%

The company’s fifty day moving average is $1.83 and its 200 day moving average is $1.85. The company has a market cap of $94.57 million, a P/E ratio of -1.39 and a beta of 1.59.

Seer (NASDAQ:SEER) last released its earnings results on Wednesday, May 13th. The company reported ($0.30) EPS for the quarter, meeting the consensus estimate of ($0.30). Seer had a negative net margin of 464.78% and a negative return on equity of 26.58%. The company had revenue of $2.79 million for the quarter, compared to analyst estimates of $3.60 million.

Hedge Funds Weigh In On Seer

Institutional investors and hedge funds have recently made changes to their positions in the business. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Seer during the 4th quarter valued at $1,510,000. Palumbo Wealth Management LLC grew its holdings in Seer by 22.4% in the 3rd quarter. Palumbo Wealth Management LLC now owns 128,980 shares of the company’s stock worth $280,000 after acquiring an additional 23,604 shares during the last quarter. GSA Capital Partners LLP grew its holdings in Seer by 31.9% in the 3rd quarter. GSA Capital Partners LLP now owns 246,667 shares of the company’s stock worth $535,000 after acquiring an additional 59,586 shares during the last quarter. Corient Private Wealth LLC grew its holdings in Seer by 46.3% in the 2nd quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock worth $135,000 after acquiring an additional 20,000 shares during the last quarter. Finally, Barclays PLC grew its holdings in Seer by 685.0% in the 4th quarter. Barclays PLC now owns 60,717 shares of the company’s stock worth $111,000 after acquiring an additional 52,982 shares during the last quarter. Institutional investors own 75.20% of the company’s stock.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.